57
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis

, , , , , , , , , , , , & show all
Pages 97-103 | Received 02 Dec 2011, Accepted 22 Mar 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ana Neves, Luísa Viveiros, Veronica Venturelli & David A Isenberg. (2023) Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities. Research and Reports in Urology 15, pages 333-353.
Read now

Articles from other publishers (9)

Juan Camilo Santacruz, Marta Juliana Mantilla, Jesús Giovanny Ballesteros, Juan Manuel Bello & John Londoño. (2023) Update on available therapies for refractory lupus nephritis. Revista Colombiana de Reumatología (English Edition) 30:4, pages 316-324.
Crossref
Chihiro Imaizumi, Takehisa Ogura, Yuki Inoue, Yuto Takakura, Takaharu Katagiri, Sayaka Takenaka, Hideki Ito, Kennosuke Mizushina, Ayako Hirata & Hideto Kameda. (2022) Reduced Rate of Disease Flares in Japanese Patients with Systemic Lupus Erythematosus: An Altered Balance between the Use of Glucocorticoids and Immunosuppressants in Recent Decades. Internal Medicine 61:21, pages 3189-3196.
Crossref
Juan Camilo Santacruz, Marta Juliana Mantilla, Jesús Giovanny Ballesteros, Juan Manuel Bello & John Londoño. (2021) Actualización de las terapias disponibles para la nefritis lúpica refractaria. Revista Colombiana de Reumatología.
Crossref
Andreas Kronbichler, Biljana Brezina, Philipp Gauckler, Luis F. Quintana & David R.W. Jayne. (2019) Refractory lupus nephritis: When, why and how to treat. Autoimmunity Reviews 18:5, pages 510-518.
Crossref
Hidetoshi Kagawa, Tsutomu Hiromasa, Ryutaro Yamanaka, Reika Hayashi, Yoko Tsunashima, Tatsuyuki Inoue & Ken-ei Sada. (2018) The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis. Clinical and Experimental Nephrology 22:6, pages 1371-1378.
Crossref
R Sakai, T Kurasawa, E Nishi, T Kondo, Y Okada, A Shibata, K Nishimura, K Chino, A Okuyama, H Takei, H Nagasawa & K Amano. (2017) Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. Lupus 27:2, pages 273-282.
Crossref
Keiji Hirai, Susumu Ookawara, Taisuke Kitano, Haruhisa Miyazawa, Kiyonori Ito, Yuichirou Ueda, Yoshio Kaku, Taro Hoshino, Honami Mori, Izumi Yoshida, Kenji Kubota, Yasuyoshi Yamaji, Tetsuro Takeda, Yoshikazu Nakamura, Kaoru Tabei & Yoshiyuki Morishita. (2017) Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial. Kidney Research and Clinical Practice 36:2, pages 159-166.
Crossref
Tak Mao Chan. (2014) Treatment of severe lupus nephritis: the new horizon. Nature Reviews Nephrology 11:1, pages 46-61.
Crossref
Jennifer H. Austin, Leah E. Bentley, Denise M. Kolanczyk & Nishil P. Patel. (2013) Refractory Proliferative Lupus Nephritis. Journal of Pharmacy Technology 29:6, pages 265-282.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.